Microneedling: Modest, Real, and Frequently Oversold
Microneedling occupies an awkward position in aesthetic practice: the evidence supports a modest, real benefit, and the marketing around it promises something considerably larger. Practitioners who present it accurately tend to have satisfied patients; those who adopt the marketing tend to have patients who feel misled after three sessions.
What it does
Controlled micro-injury to the dermis provokes a wound-healing response and, over subsequent weeks, new collagen. The clearest benefits are in atrophic acne scarring and in general skin quality — texture, tone and the appearance of fine lines. Improvement accumulates across a course of treatments and continues for some time after the last one, which is why assessing after a single session is meaningless [2].
What it does not do is tighten lax skin, replace volume, or remove deep static wrinkles. A patient whose real concern is descent or volume loss will be disappointed regardless of how well the procedure is performed.
Depth and endpoint
Depth is selected for the area and the indication, and the specific figures belong to the device's guidance rather than to an article. What can be said generally is that deeper is not better: excessive depth, repeated passes over the same area and pushing toward pinpoint bleeding across the whole face increase inflammation without increasing benefit, and inflammation is precisely what produces pigmentary complications.
The endpoint that experienced practitioners work to is light, even erythema — not a dramatic result at the end of the session. In richly pigmented skin this conservatism matters more, because the same excess inflammation that produces a modest improvement in one patient produces months of hyperpigmentation in another [3].
Device class is not a detail
Devices that penetrate the skin for a medical purpose are regulated, and that framework covers manufacture, labelling and traceability. In practice this matters in two specific ways [1].
First, needle cartridges are single-use. Reuse is an infection risk that no cleaning protocol resolves, and it is the kind of shortcut that ends a practice rather than saving money.
Second, the home-use rollers patients buy online are a different proposition from professional devices, and patients frequently combine them with clinic treatment without mentioning it. Ask.
Radiofrequency-assisted microneedling is a separate procedure with a separate risk profile — it adds heat, and heat reintroduces the thermal considerations that plain microneedling avoids. It should not be treated as the same thing with an upgrade.
Who should not be treated
- Anyone with active infection, inflammatory acne or a herpes outbreak in the area.
- Patients with a history of keloid or hypertrophic scarring.
- Anyone with an active pigmentary disorder that inflammation could worsen — melasma in particular.
- Patients on medication or with conditions affecting wound healing, without a discussion with their own doctor.
- Anyone expecting tightening, volume restoration or a single-session result.
What the patient should be told
That a course is required rather than a session; that improvement is gradual and continues after treatment finishes; that redness lasting a day or two is normal; that sun protection between sessions is part of the treatment rather than advice; and that the realistic outcome is better skin quality, not a different face.
Photograph consistently. Gradual improvement is exactly the kind that patients fail to notice without a comparison, and the same photographs protect against a complaint that nothing changed.
The professional point
Microneedling is a good, low-risk procedure sold badly. Describing it accurately costs a few sessions of upfront enthusiasm and buys a patient who returns, which in a treatment that only works as a course is the difference between a service and a disappointment.